Meristem Family Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$382K Hold
1,606
0.04% 225
2021
Q4
$367K Sell
1,606
-194
-11% -$42.7K 0.03% 272
2021
Q3
$348K Sell
1,800
-1,268
-41% -$257K 0.03% 282
2021
Q2
$653K Buy
3,068
+184
+6% +$38.8K 0.1% 143
2021
Q1
$589K Buy
2,884
+600
+26% +$118K 0.12% 116
2020
Q4
$416K Sell
2,284
-23
-1% -$3.91K 0.09% 137
2020
Q3
$386K Buy
2,307
+853
+59% +$144K 0.1% 122
2020
Q2
$236K Hold
1,454
0.06% 161
2020
Q1
$251K Sell
1,454
-15
-1% -$2.99K 0.08% 148
2019
Q4
$295K Hold
1,469
0.07% 145
2019
Q3
$310K Buy
1,469
+65
+5% +$13.6K 0.08% 140
2019
Q2
$273K Hold
1,404
0.08% 128
2019
Q1
$231K Hold
1,404
0.08% 124
2018
Q4
$264K Buy
+1,404
New +$259K 0.1% 104

Other funds holding CME

Meristem Family Wealth's CME Position: Q1 2022 in Review

Meristem Family Wealth held its CME Group (CME) position steady in Q1 2022 at 1,606 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #225.

Meristem Family Wealth first reported a position in CME in Q4 2018 and has held it in 14 quarters since. The position peaked at $653K in Q2 2021. 1,183 funds tracked by Wall St. Rank hold CME as of Q1 2022.

  • Meristem Family Wealth held 1,606 shares of CME Group worth $382K as of Q1 2022.
  • Meristem Family Wealth left its CME Group share count unchanged in Q1 2022.
  • CME Group made up 0.04% of Meristem Family Wealth's portfolio in Q1 2022, its #225 holding.
  • Meristem Family Wealth first reported a position in CME Group in Q4 2018 and has held it in 14 quarters since.
  • Meristem Family Wealth's CME Group position peaked at $653K in Q2 2021.
  • 1,183 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.